This discrepancy could be explained by different AMD stages as RPE from donors with early AMD might first express higher PGC-1α levels as a compensatory response to excessive oxidative stress and due to higher mTOR activity75,  however, what is biologically relevant is PGC-1α activity. This evidence concerns the gene PPARGC1A and age-related macular degeneration.